Is Keflex (cephalexin) effective against Enterococcus urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keflex Does Not Provide Reliable Coverage for Enterococcus UTI

Keflex (cephalexin) should not be used to treat Enterococcus urinary tract infections because first and second-generation cephalosporins lack reliable activity against Enterococcus species. 1

Why Cephalexin Fails Against Enterococcus

  • Enterococcus species are intrinsically resistant to cephalosporins, including first-generation agents like cephalexin, due to their low-affinity penicillin-binding proteins. 2

  • While cephalexin achieves high urinary concentrations and works well against typical uropathogens like E. coli, Proteus, and Klebsiella, it does not cover Enterococcus species that commonly cause complicated UTIs. 1, 3

  • Historical susceptibility testing from 1970 demonstrated that cephalothin and cephaloridine (first-generation cephalosporins) showed poor activity against Enterococcus, even when pH was optimized. 2

Appropriate Treatment Options for Enterococcal UTI

For Uncomplicated Lower UTI (Cystitis)

  • Fosfomycin 3g PO single dose is FDA-approved specifically for UTI caused by E. faecalis and represents an excellent oral option. 1, 4

  • Nitrofurantoin 100mg PO every 6 hours for 5-7 days has good in vitro activity against vancomycin-resistant Enterococcus (VRE) and is appropriate for lower UTI. 1, 4

  • Ampicillin 500mg PO/IV every 8 hours remains the drug of choice for ampicillin-susceptible Enterococcus infections. 1

For Complicated UTI or Pyelonephritis

  • Ampicillin 2g IV every 6 hours plus gentamicin is recommended as empirical treatment for complicated UTI with systemic symptoms when Enterococcus is suspected. 1, 4

  • High-dose ampicillin (18-30g IV daily) or amoxicillin (500mg every 8 hours) can overcome ampicillin resistance in urinary tract infections due to high urinary drug concentrations, with clinical cure rates of 88.1% even for ampicillin-resistant VRE. 1, 5

For Vancomycin-Resistant Enterococcus (VRE)

  • Linezolid 600mg IV/PO every 12 hours is effective for VRE infections, though it should be avoided for bacteremia due to its bacteriostatic nature. 1, 4

  • Daptomycin 8-12 mg/kg IV daily is preferred for serious VRE infections requiring bactericidal activity, but should not be used for UTI as monotherapy. 1

Critical Clinical Pitfalls

  • Do not treat asymptomatic bacteriuria with Enterococcus, as this fosters resistance without clinical benefit and represents colonization rather than true infection. 1, 4

  • Obtain urine culture with susceptibility testing before initiating therapy for Enterococcus UTI, as resistance patterns are unpredictable. 4

  • Remove indwelling urinary catheters immediately if present, as catheterization is a major risk factor for enterococcal UTI and may represent the primary source requiring control. 1, 4

  • Differentiate between E. faecalis and E. faecium, as E. faecium tends to have higher resistance rates and worse outcomes, particularly with VRE strains. 1

Treatment Duration

  • 5-7 days for uncomplicated lower UTI (cystitis) is sufficient with appropriate agents like fosfomycin or nitrofurantoin. 4

  • 7-14 days for complicated UTI, with 14 days recommended for men when prostatitis cannot be excluded. 1, 4

  • 10-14 days for pyelonephritis or bloodstream infection to ensure adequate source control and prevent relapse. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cephalexin in the therapy of infections of the urinary tract.

Postgraduate medical journal, 1983

Guideline

Treatment of Polymicrobial UTI with Enterococcus and Pseudomonas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Aminopenicillins for treatment of ampicillin-resistant enterococcal urinary tract infections.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.